Tamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I(2 )production by rat liver cells

BACKGROUND: Tamoxifen is being used successfully to treat breast cancer. However, tamoxifen also increases the risk of developing endometrial cancer in postmenopausal women. Raloxifene also decreases breast cancer in women at high risk and may have a lower risk at developing cancer of the uterus. Ta...

Descripción completa

Detalles Bibliográficos
Autor principal: Levine, Lawrence
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC514706/
https://www.ncbi.nlm.nih.gov/pubmed/15310397
http://dx.doi.org/10.1186/1471-2407-4-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC514706/
https://www.ncbi.nlm.nih.gov/pubmed/15310397
http://dx.doi.org/10.1186/1471-2407-4-49

Ejemplares similares